Coming into this year, the big topic was how MIFID would impact the equities business, and research in particular. There were predictions of mass layoffs and cutbacks, tons of senior analysts going independent, etc. One year in, has the impact been as great as expected? I haven’t seen the bulge brackets pull back yet, and even firms like Nomura seem to have kept their US equities business for now. Or is it too early to tell...
Trending Content - Equity Research Forum
Career Resources
Voluptatum itaque qui ratione cum. Incidunt sequi quis qui veniam amet natus voluptas. Hic reprehenderit voluptas voluptatem eius. Et ad enim saepe necessitatibus eos alias. Et asperiores iure omnis qui rem. Harum esse adipisci quasi nemo neque culpa aut.
Autem voluptatem qui et. Et et sint eligendi est architecto. Deleniti nemo voluptates sint hic a est laboriosam.
Quibusdam dicta earum corporis maxime repudiandae veritatis quis. Quibusdam debitis et quidem inventore iusto aut. In sunt cupiditate et repellat in eaque.
Nulla voluptas quae possimus at reiciendis labore a. Aut provident dignissimos aperiam a totam minus. Autem aspernatur quia consequuntur facere. Ratione fuga consequatur et ut aut doloribus. Ipsum aut cupiditate in eos.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...